c="osteogenesis imperfecta" 1:3 1:4||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="osteogenesis imperfecta (OI" 2:11 2:13||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="G-T transversion" 2:93 2:94||t="problem"||cui="C1705167"||tot="Nucleotide Transversion Abnormality"||ns="-827"
c="one pro alpha 2" 2:101 2:104||t="medication"||cui="C0591905"||tot="One-Alpha"||ns="-875"
c="again severe OI" 2:112 2:114||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-861"
c="severe phenotypes" 2:227 2:228||t="problem"||cui="C1836408"||tot="Severe phenotype"||ns="-981"
